Search
Recent Cases Interpreting the Federal Arbitration Act: Badgerow v. Walters & More! Litigation Associate Stephanie Denker will join a panel and discuss important decisions impacting arbitration waivers, petitions to confirm arbitral awards under 9 U.S.C. §9 and petitions to vacate arbitral awards...
The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...
Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...
Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...
Don Lussier represents clients in complex matters involving a wide range of commercial assets across the United States, including real estate, corporate and commercial lending transactions. Clients appreciate his ability to efficiently identify the issues that really matter, and to find creative and...
Veronica McCarty is a litigator who represents inventors and companies in intellectual property disputes, particularly for inventions involving computing and biopharmaceutical technologies, as well as medical devices. Veronica works on patent trials, including on ANDA bench trials, and she assists...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
Richard Forsten has more than 25 years of experience in land use and land use litigation, commercial and real estate transactions and litigation, financings, construction and mechanics' lien law, environmental law and permitting. His appearances in Delaware courts range from making en banc arguments...
Wendie Stabler provides trusted legal counsel to clients across the country on commercial real estate deals (including leases, dispositions and acquisitions) as well as developments, redevelopments and expansions. Wendie's legal work also includes a wide array of projects promoting sustainable...
Jason M. St. John is managing partner of Saul Ewing. As the chief executive officer, Jason oversees the firm's daily operations, client relations, strategic planning, business development and growth strategies. In leading Saul Ewing's national practice of 425 attorneys through its 18 offices located...
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
Amy Kline is a commercial litigator whose practice is focused on the representation of insurers and reinsurers in complex civil litigation. She is co-chair of the firm's Insurance Group and a member of the Executive Committee. Amy has extensive trial and appellate experience in federal and state...